{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T06:10:41Z","timestamp":1656051041006},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T00:00:00Z","timestamp":1371081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00105-012-2519-4","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T15:58:56Z","timestamp":1370966336000},"page":"500-505","source":"Crossref","is-referenced-by-count":3,"title":["Systemische Therapie der Rosazea"],"prefix":"10.1007","volume":"64","author":[{"given":"M.","family":"Schaller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Belge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,13]]},"reference":[{"key":"2519_CR1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","volume":"47","author":"Akhyani","year":"2008","unstructured":"Akhyani M, Ehsani AH, Ghiasi M, Jafari AK (2008) Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial. Int J Dermatol 47(3):284\u2013288","journal-title":"Int J Dermatol"},{"key":"2519_CR2","first-page":"149","volume":"80","author":"Allen","year":"2007","unstructured":"Allen KJ, Davis CL, Billings SD, Mousdicas N (2007) Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin. Cutis 80(2):149\u2013151","journal-title":"Cutis"},{"key":"2519_CR3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4065\/74.6.613","volume":"74","author":"Alvarez-Elcoro","year":"1999","unstructured":"Alvarez-Elcoro S, Enzler MJ (1999) The macrolides: erythromycin, clarithromycin, and azithromycin. Mayo Clin Proc 74(6):613\u2013634","journal-title":"Mayo Clin Proc"},{"key":"2519_CR4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2009.03132.x","volume":"23","author":"Bakar","year":"2009","unstructured":"Bakar O, Demircay Z, Toker E, Cakir S (2009) Ocular signs, symptoms and tearfunction tests of papulopustular rosacea patients receiving azithromycin. J Eur Acad Dermatol Venereol 23(5):544\u2013549","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2519_CR5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1468-3083.2001.00325.x","volume":"15","author":"Bormann","year":"2001","unstructured":"Bormann G, Gaber G, Fischer M, Marsch WC (2001) Dapsone in rosacea fulminans. J Eur Acad Dermatol Venereol 15(5):465\u2013467","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2519_CR6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.coi.2012.07.010","volume":"24","author":"Camous","year":"2012","unstructured":"Camous X, Calbo S, Picard D, Musette P (2012) Drug reaction with eosinophilia and systemic symptoms: an update on pathogenesis. Curr Opin Immunol 24(6):730\u2013735","journal-title":"Curr Opin Immunol"},{"key":"2519_CR7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2133.1993.tb00476.x","volume":"129","author":"Coleman","year":"1993","unstructured":"Coleman MD (1993) Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 129(5):507\u2013513","journal-title":"Br J Dermatol"},{"key":"2519_CR8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jaad.2005.07.021","volume":"53","author":"Craige","year":"2005","unstructured":"Craige H, Cohen JB (2005) Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol. J Am Acad Dermatol 53(5):881\u2013884","journal-title":"J Am Acad Dermatol"},{"key":"2519_CR9","first-page":"573","volume":"7","author":"Del","year":"2008","unstructured":"Del Rosso JQ, Schlessinger J, Werschler P (2008) Comparison of anti-inflammatory dose doxycycline versus doxycycline 100\u00a0mg in the treatment of rosacea. J Drugs Dermatol 7(6):573\u2013576","journal-title":"J Drugs Dermatol"},{"key":"2519_CR10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archderm.134.7.884","volume":"134","author":"Erdogan","year":"1998","unstructured":"Erdogan FG, Yurtsever P, Aksoy D, Eskioglu F (1998) Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 134(7):884\u2013885","journal-title":"Arch Dermatol"},{"key":"2519_CR11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0190-9622(99)70022-8","volume":"41","author":"Forstinger","year":"1999","unstructured":"Forstinger C, Kittler H, Binder M (1999) Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream. J Am Acad Dermatol 41(5 Pt 1):775\u2013777","journal-title":"J Am Acad Dermatol"},{"key":"2519_CR12","first-page":"996","volume":"7","author":"Gauwerky","year":"2009","unstructured":"Gauwerky K, Kl\u00f6vekorn W, Korting HC et al (2009) Rosacea. J Dtsch Dermatol Ges 7(11):996\u20131003","journal-title":"J Dtsch Dermatol Ges"},{"key":"2519_CR13","first-page":"505","volume":"8","author":"Gollnick","year":"2010","unstructured":"Gollnick H, Blume-Peytavi U, Szab\u00f3 EL et al (2010) Systemic isotretinoin in the treatment of rosacea \u2013 doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 8(7):505\u2013515","journal-title":"J Dtsch Dermatol Ges"},{"key":"2519_CR14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2012.04.017","volume":"67","author":"Hsu","year":"2012","unstructured":"Hsu CC, Lee JY (2012) Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective \u03b2-adrenergic blocker. J Am Acad Dermatol 67(3):491\u2013493","journal-title":"J Am Acad Dermatol"},{"key":"2519_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000247160","volume":"188","author":"Jansen","year":"1994","unstructured":"Jansen T, Plewig G, Kligman AM (1994) Diagnosis and treatment of rosacea fulminans. Dermatology 188(4):251\u2013254","journal-title":"Dermatology"},{"key":"2519_CR16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-2008-1064456","volume":"14","author":"Jansen","year":"1998","unstructured":"Jansen T, Plewig G (1998) Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg 14(4):241\u2013253","journal-title":"Facial Plast Surg"},{"key":"2519_CR17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2008.02589.x","volume":"22","author":"Karabulut","year":"2008","unstructured":"Karabulut AA, Izol Serel B, Eksioglu HM (2008) A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1\u2009% for papulopustular rosacea. J Eur Acad Dermatol Venereol 22(6):729\u2013734","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2519_CR18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3346\/jkms.2011.26.5.694","volume":"26","author":"Kim","year":"2011","unstructured":"Kim JH, Oh YS, Choi EH (2011) Oral azithromycin for treatment of intractable rosacea. J Korean Med Sci 26(5):694\u2013696","journal-title":"J Korean Med Sci"},{"key":"2519_CR19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000235550","volume":"22","author":"Korting","year":"2009","unstructured":"Korting HC, Sch\u00f6llmann C (2009) Tetracycline actions relevant to rosacea treatment. Skin Pharmacol Physiol 22:287\u2013294","journal-title":"Skin Pharmacol Physiol"},{"key":"2519_CR20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s001050050577","volume":"48","author":"Krause","year":"1997","unstructured":"Krause MH, Torricelli R, K\u00fcndig T et al (1997) Dapson bei granulomat\u00f6ser Rosazea. Hautarzt 48(4):246\u2013248","journal-title":"Hautarzt"},{"key":"2519_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1529-8019.2006.00075.x","volume":"19","author":"Kroshinsky","year":"2006","unstructured":"Kroshinsky D, Glick SA (2006) Pediatric rosacea. Dermatol Ther 19:196\u2013201","journal-title":"Dermatol Ther"},{"key":"2519_CR22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/14656566.5.3.541","volume":"5","author":"Labro","year":"2004","unstructured":"Labro MT (2004) Macrolide antibiotics: current and future uses. Expert Opin Pharmacother 5(3):541\u2013550","journal-title":"Expert Opin Pharmacother"},{"key":"2519_CR23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1365-2133.2012.10845.x","volume":"166","author":"Lebrun-Vignes","year":"2012","unstructured":"Lebrun-Vignes B, Kreft-Jais C, Castot A, Chosidow O (2012) Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. Br J Dermatol 166(6):1333\u20131341","journal-title":"Br J Dermatol"},{"key":"2519_CR24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00105-005-1009-3","volume":"56","author":"Lehmann","year":"2005","unstructured":"Lehmann P (2005) Rosazea. Klinik, Pathogenese, Therapie. Hautarzt 56:871\u2013885","journal-title":"Hautarzt"},{"key":"2519_CR25","first-page":"54","volume":"4","author":"Park","year":"2011","unstructured":"Park H, Del Rosso JQ (2011) Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol 4(9):54\u201361","journal-title":"J Clin Aesthet Dermatol"},{"key":"2519_CR26","first-page":"904","volume":"9","author":"Pfeffer","year":"2011","unstructured":"Pfeffer I, Borelli C, Zierhut M, Schaller M (2011) Treatment of ocular rosacea with 40\u00a0mg doxycycline in a slow release form. J Dtsch Dermatol Ges 9(11):904\u2013907","journal-title":"J Dtsch Dermatol Ges"},{"key":"2519_CR27","doi-asserted-by":"crossref","unstructured":"Plewig G (2005) Akne und Rosazea. In: Braun-Falco O, Plewig G, Wolff H et al (Hrsg) Dermatologie und Venerologie. Springer, Berlin, S\u00a0885\u2013909","DOI":"10.1007\/3-540-26624-0_61"},{"key":"2519_CR28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(76)92160-7","volume":"1","author":"Pye","year":"1976","unstructured":"Pye RJ, Burton JL (1976) Treatment of rosacea by metronidazole. Lancet 1(7971):1211\u20131212","journal-title":"Lancet"},{"key":"2519_CR29","unstructured":"Rote Liste, Februar 2012. Rote Liste\u00ae Service GmbH, Frankfurt\/Main"},{"key":"2519_CR30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","volume":"54","author":"Sapadin","year":"2006","unstructured":"Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258\u2013265","journal-title":"J Am Acad Dermatol"},{"key":"2519_CR31","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0190-9622(03)00743-6","volume":"49","author":"Schaller","year":"2003","unstructured":"Schaller M, Sander CA, Plewig G (2003) Demodexabscesses: clinical and therapeutic challenges. J Am Acad Dermatol 49(5 Suppl):S272\u2013S274","journal-title":"J Am Acad Dermatol"},{"key":"2519_CR32","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00105-009-1825-y","volume":"60","author":"Sobottka","year":"2009","unstructured":"Sobottka A, Lehmann P (2009) Rosazea 2009. Neue Erkenntnisse zur Pathophysiologie, klinische Manifestationsformen und Therapiestrategien. Hautarzt 60:999\u20131009","journal-title":"Hautarzt"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2519-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-012-2519-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2519-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T05:26:42Z","timestamp":1563168402000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-012-2519-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,13]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2519"],"URL":"https:\/\/doi.org\/10.1007\/s00105-012-2519-4","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,13]]}}}